DaVita
DVA
#1687
Rank
C$17.58 B
Marketcap
C$273.91
Share price
0.91%
Change (1 day)
40.33%
Change (1 year)
DaVita Inc. is an American company providing dialysis services for patients with chronic and acute kidney failure.

EPS for DaVita (DVA)

EPS in 2026 (TTM): C$15.15

According to DaVita's latest financial reports the company's current EPS (TTM) is C$15.17. In 2025 the company made an earnings per share (EPS) of C$13.95 a decrease over its 2024 EPS that were of C$15.21.

EPS history for DaVita from 2012 to 2026

Annual EPS

Year EPS Change
2026 (TTM)C$15.158.57%
2025C$13.95-8.25%
2024C$15.2144.94%
2023C$10.4927.26%
2022C$8.25-35.56%
2021C$12.8044.1%
2020C$8.8819.7%
2019C$7.42540.48%
2018C$1.16-76.07%
2017C$4.84-19.31%
2016C$6.00242.52%
2015C$1.75-62.87%
2014C$4.7213.43%
2013C$4.168.45%
2012C$3.83

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Universal Health Services
UHS
C$33.52 121.00%๐Ÿ‡บ๐Ÿ‡ธ USA
LabCorp
LH
C$15.66 3.27%๐Ÿ‡บ๐Ÿ‡ธ USA
Tenet Healthcare
THC
C$26.82 76.82%๐Ÿ‡บ๐Ÿ‡ธ USA
Pediatrix Medical Group
MD
C$2.66-82.45%๐Ÿ‡บ๐Ÿ‡ธ USA